サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561447

放射線治療市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年

Radiotherapy Market Report by Type, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
放射線治療市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射線治療市場の市場規模は2023年に68億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに97億米ドルに達し、2024年から2032年の間に3.9％の成長率（CAGR）を示すと予測しています。がん罹患率の上昇、技術の進歩、腫瘍ターゲティングの精度の向上、ヘルスケア支出の増加、非侵襲的がん治療オプションとしての放射線治療の利点に対する認知度の高まりなどが、市場成長の明るい見通しを生み出しています。

放射線治療市場分析：

  • 主な市場促進要因：放射線治療市場は、世界のがん罹患率の上昇によって、非侵襲的で効率的な治療オプションに対する需要が高まっていることが主な要因です。このほか、先進的な放射線治療へのアクセスが容易な発展途上地域における医療支出の増加やヘルスケアインフラの改善が、放射線治療の需要を後押ししています。
  • 主な市場動向：強度変調放射線治療（IMRT）や画像誘導放射線治療（IGRT）の開発など、放射線治療装置の技術的進歩は主要な動向の一つです。同時に、治療計画と治療を改善する放射線治療における人工知能（AI）の統合も、より個別化された効果的ながん治療につながる新たな動向です。
  • 地理的動向：放射線治療市場予測では、高度なヘルスケアインフラ、高額な医療費、新技術の早期導入により、北米が主要地域であることが明らかになった。同地域の強力な規制の枠組みやがん研究への多額の投資も、主導的な地位に貢献しています。さらに、アジア太平洋地域は、ヘルスケアに対する意識の高まり、がん罹患率の上昇、ヘルスケア施設の改善により、急速な成長を遂げています。
  • 競合情勢：主な放射線治療企業には、Accuray Incorporated、Becton Dickinson and Company、Eckert &Ziegler、Elekta AB（publ）、General Electric Company、日立製作所、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nordion Inc.（Sotera Health）、Siemens Healthineers AG（Siemens AG）などがあります。
  • 課題と機会：放射線治療市場の概要によると、多くの患者やヘルスケアシステムにとって法外な金額となり得る放射線治療システムや治療費の高さが、市場成長の大きな制約となっています。しかし、この課題は放射線治療市場に、費用対効果の高い治療モデルの開発や、より合理的な技術の導入という最近の動向をもたらしています。これとともに、先進放射線治療技術の安全かつ効果的な使用を保証するために、新興国市場で臨床医に対するトレーニングや教育が拡大していることも、放射線治療市場の展望にプラスの影響を与えています。

放射線治療市場動向：

技術の進歩

放射線治療市場強度変調放射線治療（IMRT）や画像誘導放射線治療（IGRT）といった最近の動向や技術革新は、がん治療の精度と有効性を大幅に向上させ、市場拡大の一助となっています。IGRTでは、放射線治療セッション中にリアルタイムの画像を使用することで、治療と治療の間に移動があったとしても、腫瘍を正確に狙い撃ちすることができます。これにより、腫瘍医は治療中にビーム強度を変化させることで放射線量を調節し、周囲の健康な組織への被ばくを最小限に抑えながら、腫瘍の形状に合わせて効果的に放射線を照射することができます。さらにIAEAは2020年4月、定位分割放射線治療（SFRT）が肺がんや子宮頸がんの緩和治療をどのように強化できるかを研究するプロジェクトを開始しました。

放射線治療における人工知能（AI）の統合

AI技術は、計画プロセスの合理化、放射線照射の精度の向上、治療スケジュールの最適化に利用されています。機械学習（ML）アルゴリズムは、画像や治療記録の大規模なデータセットを分析してパターンを特定し、個々の患者に合わせた最適な治療アプローチを予測することができます。AIはまた、様々な放射線治療に対する患者の反応予測モデルの開発にも活用されており、これは、継続的なセッションに対する患者の反応に基づいて治療を調整する適応放射線治療に使用することができます。放射線科医は40年間で約22万5000件のMRI/CT検査を見ているが、AIは22万5000件のスキャンから始めて自己訓練し、短期間で数百万件のスキャンに到達することができます。これにより、業務が効率化され、ヘルスケア・サービスがより多くの人々に拡大し、放射線治療市場の収益が向上します。

個別化医療へのシフト

がん治療における個別化医療へのシフトは、放射線治療市場にますます影響を与えています。個別化医療とは、患者一人ひとりの特性に合わせた治療を行うことであり、放射線治療においては、治療効果に影響を与える可能性のある遺伝的、表現型的、環境的要因に基づいて放射線量やスケジュールをカスタマイズすることを意味します。ヘルスケアプロバイダーは、患者に合わせた治療に専念することで、好ましくない副作用の発生率を減らし、治療効果を高めることができます。個別化医療連合の報告書によると、米国市場における個別化医薬品の数は2016年から2020年にかけて倍増しました。2019年にFDAが承認した新薬の25％を占めるこれらの医薬品は、132から286に増加し、2005年の5％から大幅な伸びを示しました。この成長が放射線治療市場のシェアを押し上げています。

本レポートで扱う主な質問

  • 世界の放射線治療市場はこれまでどのように推移してきたか？
  • 世界の放射線治療市場における促進要因、抑制要因、機会は何か？
  • 促進要因、抑制要因、機会が世界の放射線治療市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な放射線治療市場はどの国か？
  • タイプ別の市場内訳は？
  • 放射線治療市場で最も魅力的なタイプは？
  • 用途別の市場内訳は？
  • 放射線治療市場で最も魅力的なアプリケーションは？
  • エンドユーザー別の市場内訳は？
  • 放射線治療市場で最も魅力的なエンドユーザーは？
  • 市場の競合構造は？
  • 世界の放射線治療市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の放射線治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 外部放射線治療
    • 市場動向
    • 主要セグメント
      • 強度変調放射線治療（IMRT）
      • 画像誘導放射線治療（IGRT）
      • トモセラピー
      • 定位放射線手術
      • 定位放射線治療
      • 陽子線治療
      • 3D原体放射線治療（3D CRT）
      • 体積変調アーク治療（VMAT）
    • 市場予測
  • 内部放射線療法/近接放射線療法
    • 市場動向
    • 市場予測
  • 全身放射線療法
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 皮膚がんおよび唇がん
    • 市場動向
    • 市場予測
  • 頭頸部がん
    • 市場動向
    • 市場予測
  • 乳がん
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • 子宮頸がん
    • 市場動向
    • 市場予測
  • 肺がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • がん調査機関
    • 市場動向
    • 市場予測
  • 外来・放射線治療センター
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Eckert & Ziegler
    • Elekta AB（publ）
    • General Electric Company
    • Hitachi Ltd
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion Inc.（Sotera Health）
    • Siemens Healthineers AG（Siemens AG）
図表

List of Figures

  • Figure 1: Global: Radiotherapy Market: Major Drivers and Challenges
  • Figure 2: Global: Radiotherapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Radiotherapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Radiotherapy Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Radiotherapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Radiotherapy Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Radiotherapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Radiotherapy (External Beam Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Radiotherapy (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Radiotherapy (Internal Radiation Therapy/Brachytherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Radiotherapy (Systemic Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Radiotherapy (Systemic Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Radiotherapy (Skin and Lip Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Radiotherapy (Skin and Lip Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Radiotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Radiotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Radiotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Radiotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Radiotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Radiotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Radiotherapy (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Radiotherapy (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Radiotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Radiotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Radiotherapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Radiotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Radiotherapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Radiotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Radiotherapy (Cancer Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Radiotherapy (Cancer Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Radiotherapy (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Radiotherapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Radiotherapy Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Radiotherapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Radiotherapy Industry: SWOT Analysis
  • Figure 84: Global: Radiotherapy Industry: Value Chain Analysis
  • Figure 85: Global: Radiotherapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiotherapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Radiotherapy Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Radiotherapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Radiotherapy Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Radiotherapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Radiotherapy Market: Competitive Structure
  • Table 7: Global: Radiotherapy Market: Key Players
目次
Product Code: SR112024A4413

The global radiotherapy market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032. The rise in cancer incidence, advancements in technology, increasing precision in tumor targeting, growing healthcare expenditure, and heightened awareness of radiotherapy's benefits as a non-invasive cancer treatment option are some of the factors creating a positive outlook for the market growth.

Radiotherapy Market Analysis:

  • Major Market Drivers: The market for radiotherapy is primarily driven by the rising incidence of cancer worldwide, which is creating a demand for non-invasive, efficient treatment options. Besides this, the increased healthcare spending and improvements in healthcare infrastructure in the developing region, where access to advanced radiation treatments is more available, are bolstering the radiotherapy demand.
  • Key Market Trends: Technological advancements in radiotherapy devices, such as the development of intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), represent one of the major radiotherapy market trends. Concurrently, the integration of artificial intelligence (AI) in radiotherapy improving treatment planning and delivery is another emerging trend leading to more personalized and effective cancer care.
  • Geographical Trends: The radiotherapy market forecast revealed North America as the dominating region due to its advanced healthcare infrastructure, high healthcare expenditure, and early adoption of new technologies. The region's strong regulatory framework and substantial investments in cancer research also contribute to its leading position. Furthermore, Asia Pacific is experiencing rapid growth, driven by increasing healthcare awareness, rising cancer prevalence, and improving healthcare facilities.
  • Competitive Landscape: Some of the major radiotherapy companies are Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health) and Siemens Healthineers AG (Siemens AG) among many others.
  • Challenges and Opportunities: According to the radiotherapy market overview, the high cost of radiotherapy systems and treatments, which can be prohibitive for many patients and healthcare systems, is a major constraint for the market growth. However, this challenge presents the radiotherapy market with recent opportunities for the development of cost-effective treatment models and the introduction of more reasonable technology. Along with this, the expansion of training and education for clinicians in developing markets to ensure the safe and effective use of advanced radiotherapy technologies is positively impacting the radiotherapy market outlook.

Radiotherapy Market Trends:

Technological advancements

Radiotherapy market recent developments and innovations such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) have greatly improved the precision and effectiveness of cancer treatments, aiding in market expansion. IGRT involves the use of real-time imaging during radiation therapy sessions, ensuring that the tumor is accurately targeted, even if there is movement between treatments. This allows oncologists to modulate the radiation dose by varying the beam intensity during treatment, effectively conforming the radiation dose to the shape of the tumor while minimizing exposure to surrounding healthy tissues. Moreover, in April 2020, the IAEA started a project to study how Stereotactic Fractionated Radiotherapy (SFRT) can enhance palliative treatment for lung and cervical cancers, aiming to alleviate symptoms and slow down disease progression, which is further aiding in market expansion.

Integration of artificial intelligence (AI) in radiotherapy

AI technologies are being used to streamline the planning process, improve the accuracy of radiation dosing, and optimize treatment schedules. Machine learning (ML) algorithms can analyze large datasets of imaging and treatment records to identify patterns and predict optimal treatment approaches tailored to individual patients. AI is also being utilized to develop predictive models for patient responses to various radiation therapies, which can be used in adaptive radiotherapy to adjust treatments based on the patient's response to ongoing sessions. Radiologists look at approximately 225,000 MRI/CT exams in 40 years, while AI can start with 225,000 scans to train itself and reach millions of scans within a very short period of time. This will streamline operations and expand healthcare services to a larger population, thereby boosting radiotherapy market revenue.

Shift toward personalized medicine

The growing shift towards personalized medicine in cancer treatment is increasingly influencing the radiotherapy market. Personalized medicine approaches involve tailoring medical treatment to the individual characteristics of each patient, and in the context of radiotherapy, this means customizing radiation doses and schedules based on genetic, phenotypic, and environmental factors that could affect treatment response. Healthcare providers can reduce the incidence of unfavorable side effects and increase treatment efficacy by concentrating on individualized patient care. The Personalized Medicine Coalition's report indicates that the number of personalized medicines in the US market doubled between 2016 and 2020. These medicines, which accounted for 25% of new drugs approved by the FDA in 2019, rose from 132 to 286, marking a significant increase from 5% in 2005. This growth is boosting the radiotherapy market share.

Radiotherapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

  • External Beam Radiation Therapy
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Image-Guided Radiation Therapy (IGRT)
    • Tomotherapy
    • Stereotactic Radiosurgery
    • Stereotactic Body Radiation Therapy
    • Proton Therapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

External beam radiation therapy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes external beam radiation therapy (intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), tomotherapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, 3D conformal radiotherapy (3D CRT), and volumetric modulated arc therapy (VMAT)), internal radiation therapy/brachytherapy and systemic radiation therapy. According to the report, external beam radiation therapy represented the largest segment.

Based on the radiotherapy market analysis, the surging demand for external beam radiation therapy (EBRT) is driven by its versatility and effectiveness in treating a wide range of cancers with precision. In line with this, EBRT remains the most common form of radiotherapy due to its ability to accurately target tumors with high-energy beams, minimizing damage to surrounding healthy tissues. Furthermore, the introduction of technologically advanced systems like three-dimensional (3D) conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT) has greatly enhanced the appeal of EBRT, creating a positive outlook for market expansion.

Breakup by Application:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

Breast cancer holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. According to the report, breast cancer accounted for the largest market share.

Radiotherapy's efficacy as a standard post-operative therapeutic strategy to prevent tumor recurrence in breast cancer represents a crucial factor driving its market demand. According to the World Health Organization (WHO), there were 2.3 million women diagnosed with breast cancer and 670,000 deaths globally in 2022. This increasing incidence of breast cancer globally necessitates effective treatment modalities, and radiotherapy is recognized for its critical role in the early and advanced stages of the disease. It is particularly effective in conserving the breast in cases of early-stage breast cancer, often used following lumpectomy to eliminate any remaining cancerous cells and significantly reduce the risk of cancer returning. Additionally, radiotherapy also helps alleviate symptoms and control tumor growth in advanced metastatic cases, which is further boosting its demand.

Breakup by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

Ambulatory and radiotherapy centers represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, cancer research institutes, and ambulatory and radiotherapy centers. According to the report, ambulatory and radiotherapy centers represented the largest segment.

As per the radiotherapy market report, its demand in ambulatory and radiotherapy centers is driven by an increasing preference for outpatient care settings, which offer cost-efficiency, convenience, and reduced patient burden compared to in-hospital treatments. Ambulatory care centers are particularly appealing because they enable patients to receive high-quality, specialized care without the need for overnight hospital stays. Additionally, these centers can often provide services at a lower cost than traditional hospital settings due to their specialized nature and efficiency in managing specific treatments like radiotherapy. This cost-effectiveness attracts patients and healthcare payers seeking to manage expenditures. Furthermore, the proliferation of radiotherapy centers and technological advancements that make sophisticated radiotherapy equipment more compact and affordable, are propelling the market forward.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest radiotherapy market share.

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for radiotherapy.

The demand for radiotherapy in North America is propelled by numerous factors such as well-established healthcare infrastructure, robust funding for cancer research, and the high prevalence of cancer. North America boosts some of the world's leading cancer research facilities and hospitals, which adopt and also develop cutting-edge radiotherapy technologies. In addition to this, the region benefits from substantial healthcare spending both from the public and private sectors, allowing for significant investments in advanced medical equipment and treatment modalities. Furthermore, there is a strong focus on early cancer detection and screening programs, which identify patients who can benefit from early intervention using radiotherapy, which is impelling the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the radiotherapy industry include Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), Siemens Healthineers AG (Siemens AG), etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The competitive landscape is characterized by the presence of prominent radiotherapy companies who are engaged in fierce competition through technological innovation, mergers, and acquisitions, and expansion into emerging markets. They are developing advanced radiotherapy systems with enhanced precision and adaptability and leveraging their broad technological portfolios and strong global presence to enhance their market share and penetrate new geographical regions. Additionally, specialized companies are focusing on niche technologies like brachytherapy and compact proton therapy systems, respectively to offer tailored solutions that meet specific clinical needs and gain a competitive edge in the market.

Radiotherapy Market News:

  • In May 2022, Elekta AB launched Elekta Espirit, a next-generation gamma knife that enables more personalized radiosurgery.
  • In May 2023, General Electric Company launched multiple radiotherapy instruments, including auto segmentation, intelligent radiation therapy (IRT), and an updated MR radiation therapy suite.
  • In September 2023, Siemens Healthineers acquired Aspekt to strengthen its radiation oncology services.

Key Questions Answered in This Report:

  • How has the global radiotherapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global radiotherapy market?
  • What is the impact of each driver, restraint, and opportunity on the global radiotherapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive radiotherapy market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the radiotherapy market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the radiotherapy market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the radiotherapy market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global radiotherapy market

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.2.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.2.3 Tomotherapy
      • 6.1.2.4 Stereotactic Radiosurgery
      • 6.1.2.5 Stereotactic Body Radiation Therapy
      • 6.1.2.6 Proton Therapy
      • 6.1.2.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.2.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.3 Market Forecast
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Head and Neck Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Breast Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Prostate Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cervical Cancer
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Lung Cancer
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cancer Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accuray Incorporated
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Eckert & Ziegler
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Elekta AB (publ)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Hitachi Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Ion Beam Applications
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Isoray Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Mevion Medical Systems Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Nordion Inc. (Sotera Health)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthineers AG (Siemens AG)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis